DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Diovan HCT (Valsartan / Hydrochlorothiazide) - Adverse Event Reports - Life Threatening Events - Fatigue

 



Index of reports > Cases resulting in life threatening events (7) > Cases with Fatigue (2)

Below is the selection of adverse event reports related to Diovan HCT (Valsartan / Hydrochlorothiazide) that includes cases resulting in life threatening events where reactions include fatigue.

Adverse event in 69 year old male receiving Diovan HCT (Valsartan / Hydrochlorothiazide)

Reported by a individual with unspecified qualification from United States on 2007-07-19

Patient: 69 year old male, weighing 88.4 kg (194.6 pounds)

Adverse reactions / side effects: Surgery, Renal Failure, Fatigue, Neoplasm Malignant, Pollakiuria, Renal Cell Carcinoma Stage Unspecified, Gait Disturbance, Hypertension, Lung Infiltration, Blood Creatinine Increased, Decreased Appetite, Metastases TO Lung

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
Diovan HCT (Valsartan / Hydrochlorothiazide)

Other drugs received by patient: Indocin



Adverse event in 40 year old female receiving Diovan HCT (Valsartan / Hydrochlorothiazide)

Reported by a consumer/non-health professional from Venezuela on 2007-03-15

Patient: 40 year old female

Adverse reactions / side effects: Fatigue, Renal Failure, Respiratory Disorder, Arterial Disorder, Hypotension, Abdominal Distension, Asthenia, Cardiac Disorder, Hypertensive Crisis

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Diovan HCT
    Dosage: 160/25 mg
    Indication: Hypertension
    End date: 2006-10-01

Foradil

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009